NCT00437372 2025-05-02
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Thomas Jefferson University
Phase 1 Completed
Thomas Jefferson University
The Methodist Hospital Research Institute
H. Lee Moffitt Cancer Center and Research Institute